首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1623449

全球基因組資料管理區塊鏈市場規模（按服務類型、應用、區域範圍劃分）預測至 2025 年

Global Blockchain In Genomic Data Management Market Size By Service Type (B2B Business Model and B2C Business Model), By Application (Pharmaceutical Companies and Research Institutes), By Geographic Scope And Forecast

出版日期: 2024年07月08日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

區塊鏈在基因組資料管理中的市場規模與預測

2020 年，基因組資料管理中的區塊鏈市場規模價值 3,998 萬美元，預計到 2028 年將達到 20.6752 億美元，2021 年至 2028 年的複合年增長率為 63.76%。

私人公司和創投的投資不斷增加，推動了基因組數據管理區塊鏈市場的成長。此外，基因組學的發展、數位工具的日益採用以及患者醫療服務的數位化等因素也在推動市場成長。全球基因組數據管理區塊鏈市場報告對市場進行了全面評估。它對關鍵細分市場、趨勢、市場推動因素、競爭格局以及在市場中發揮關鍵作用的因素進行了全面的分析。

基因組資料管理中區塊鏈的全球市場定義

區塊鏈是一種數位化的、以區塊形式儲存的交易和資料的公共分類帳。區塊鏈提供了一個可以在互連的資料庫系統之間共享的去中心化資料網路。區塊鏈技術採用帶有時間戳記的、不可變的資料區塊系統，使得世界上任何地方任何擁有連網系統的人只要獲得適當的授權就可以存取它。這項技術讓用戶可以控制自己的資料分發，從而保護自己的隱私。非對稱加密（公鑰加密）允許用戶加密資料以增加安全性。

但如果你出售或捐贈你的數據，接收者會得到一個私鑰來解密數據，確保未經授權的第三方無法存取它。區塊鏈技術將儲存、管理和交換基因組數據。區塊鏈採用分散的資訊管理模型，這對銀行和金融業有利。生物製藥和基因組研究公司正在使用區塊鏈來處理基因組數據提供者與其客戶之間的基因組數據交易和支付。它也有助於決策。區塊鏈平台將實現數據提供者（用戶）與購買者（藥廠、研究機構）之間的直接互動。

此外，加密金鑰還可以在資料交換過程中保持使用者的匿名性。這些買家可以使用數據集來研究特定人群的基因模式，並根據分析的基因圖譜開發藥物和其他治療方法。透過使用加密區塊，區塊鏈降低了資料修改或篡改的風險，從而為罕見疾病的新診斷和治療方法的研究和開發創建了可靠的資料庫。該技術最著名的應用是比特幣和以太坊。該技術創造了一個透明、可追溯、但不可腐蝕的鏈模型。分散的時間戳系統允許區塊鏈在沒有中央權威的情況下運行，從而防止單點故障。交易在該網路的所有參與者之間直接且安全地進行。

基因組資料管理區塊鏈的全球市場概況

私人公司和創投的投資不斷增加，推動了基因組數據管理區塊鏈市場的成長。該領域的其他近期活動，例如製藥公司和相關政府機構建立戰略合作夥伴關係，以及風險資本家/其他利益相關者的投資，都是使用區塊鏈平台來儲存和管理遺傳資訊。正在獲得醫療保健行業的支持。這些舉措可能會在未來幾年推動整個市場的成長。此外，基因組學的不斷發展、數位工具的日益採用以及患者醫療服務的數位化等因素也在推動市場成長。

當今的醫療保健資料管理系統涉及資料收集、資料共享、分析成本、資料所有權、隱私和安全。該領域最重要和最關鍵的方面是數據採集。資料雲架構旨在透過安全的方式儲存資料來解決單點故障問題。區塊鏈有可能降低基因組和醫療保健分析的價格。與現有系統的工作方式相反，如果資料所有者可以直接聯繫資料購買者，而無需透過中介，那麼這可以降低分析成本和資料所有者的收入。這些聲明也適用於電子醫療應用程式。

使用區塊鏈系統，交易可以比透過傳統流程更快、更有效率地完成。然而，對於大量的基因組和臨床數據，很少有可靠、安全的數據管理資源能夠提供安全的儲存、無縫的資訊交換和值得信賴的交易平台。然而，對資料安全和隱私的擔憂正在限制基因組資料管理的區塊鏈市場的發展。您的個人資料的安全和隱私非常重要。儘管比特幣提供了偽匿名性，但沒有系統可以提供完全匿名性。

基因組學和醫療保健領域的另一個敏感問題是人們不願意直接提供他們的原始數據。例如，透過檢查一個人的整個基因組數據，我們可以識別該人並獲得有關其祖先的資訊。區塊鏈系統中的交易以哈希值存儲，而不是原始資料。此外，個人隻共享元數據，即有關數據的一般資訊。此外，醫療器材行業的創新產品和發展以及行動智慧型手機的不斷增長的使用為該市場帶來了巨大的機會。

Rising investment by private players and venture capitalists helps to boost the Blockchain In Genomic Data Management Market growth. Moreover, factors such as rising developments in genomics, rising adoption of digital tools, and digitization of healthcare services by patients fuel the market growth. The Global Blockchain In Genomic Data Management Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Blockchain In Genomic Data Management Market Definition

Blockchain is a digitalized public ledger of transactions and data stored as blocks. Blockchain provides a decentralized network of distributable data that can be shared between interconnected database systems. Blockchain technology utilizes a timestamped immutable system of blocks containing data, making them accessible to anyone with a connected system, anywhere in the world, as long as they receive proper authorization. This technology allows users control over the distribution of their data, thereby protecting their privacy. Using asymmetric cryptography (Public Key Cryptography), users can encrypt their data for added security.

When selling or donating data, however, the receiver is granted a private key to decrypt the data, ensuring that no non-permitted third parties have access. Blockchain technology stores, manage and exchange genomic data. The blockchain utilizes a decentralized information management model that is beneficial for banking and financial areas. Blockchain is used in biopharmaceutical and genomic research companies to process the transactions of genomic data and payments between genomic data providers and their customers. It also provides help in decision-making. The blockchain platform allows data providers (users) and buyers to interact directly (pharma companies, research institutes).

Additionally, the cryptographic keys also maintain the anonymity of users during data exchange. These buyers may then use the sets of data to research genetic patterns in a specific population, allowing for the development of drugs and other therapies based on the genetic profiles analyzed. Blockchain reduces the risk of data modification and tampering by using cryptographic blocks, resulting in an authentic database for research and the creation of new diagnostics and treatment options for rare disorders. The best-known applications of this technology are Bitcoin and Ethereum. It creates a chain model that can be transparently tracked but cannot be broken. With a distributed timestamp system, blockchain permits operation without a central authority, preventing single-point-of-failure. Transactions may be carried out directly and safely among all participants in this network.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Blockchain In Genomic Data Management Market Overview

Rising investment by private players and venture capitalists helps to boost the Blockchain In Genomic Data Management Market growth. Recent activities in this domain, such as the formation of strategic partnerships (involving pharmaceutical players and relevant government bodies) and venture capital/other stakeholder investments, indicate that the concept of using blockchain platforms for the storage and management of genetic information is gaining traction in the healthcare industry. such efforts will help the market's overall growth in the coming years. Additionally, factors such as increasing developments in genomics, rising adoption of digital tools, and digitization of healthcare services by patients drive the market growth.

Today's healthcare data management systems are concerned with data collection, data sharing, analysis expenses, data ownership, privacy, and security. The most important and significant aspect of this field is obtaining data. Data Cloud Architecture was designed to address the single point of failure problem by storing data in a secure and safe way. The blockchain has the potential to reduce the price of genomics and healthcare analysis. In contrast to how the existing systems work, if data owners can contact data buyers directly without going through an intermediary, both the analysis costs and the data owners' income can be reduced. These statements apply to electronic healthcare apps as well.

Transactions are completed faster and more effectively using blockchain systems than with conventional processes. However, for large volumes of genomic and clinical data, there are few reliable and secure data management resources that would provide safe storage, seamless information exchange, and a reliable transaction platform. However, data security and privacy concerns are restraining factors for the Blockchain In Genomic Data Management Market. The security and privacy of personal data are very important. Bitcoin provides pseudo-anonymity, despite the fact that no system can give complete anonymity.

Another sensitive issue in genomics and healthcare is that people do not want to give their original data directly. For instance, by examining an individual's entire genome data, the person may be identified, and information about his or her ancestors can be obtained. Instead of the original data, transactions in blockchain systems are saved with their hash values. Individuals also only share metadata, which is information about the data in general. Furthermore, innovative products and development in the medical device industry and the increase in the use of mobile smartphones are the major opportunities in front of this market.

Global Blockchain In Genomic Data Management Market Segmentation Analysis

The Global Blockchain In Genomic Data Management Market is Segmented on the basis of Service Type, Application, And Geography.

Blockchain In Genomic Data Management Market, By Service Type

B2B Business Model
B2C Business Model
C2B Business Model

Based on Service Type, the market is segmented into B2B Business Model, B2C Business Model, and C2B Business Model. A business model is a company's plan or strategy for selling a product or service and profiting from it. Each organization will develop its own methods used to conduct business. There is, however, a central model that includes the owners or shareholders, the organization, consumers, and employees. Blockchain can act as a virtual bank for B2B companies, moving money, accepting deposits, finalizing transactions, and more. This is in contrast to online banking, which is subject to regulation, monitoring, business hours, and other restrictions.

Blockchain In Genomic Data Management Market, By Application

Pharmaceutical Companies
Research Institutes
Data Owners
Others

Based on Application, the market is segmented into Pharmaceutical Companies, Research Institutes, Data Owners, and Others. The majority of companies are involved in offering services primarily to pharmaceutical companies and research institutes. In addition, the companies also offer genomic data management through blockchain platforms to other key stakeholders such as data owners, software developers, and insurers.

Blockchain In Genomic Data Management Market, By Geography

North America
Europe
Asia Pacific
Rest of the world
On the basis of Geography, the Global Blockchain In Genomic Data Management Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. More than 35% of the total number of players are headquartered in North America, primarily in the United States. EncrypGen, GnoMine, LunaDNA, and Nebula Genomics are some of the players based in this region.

Key Players

The "Global Blockchain In Genomic Data Management Market" study report will provide a valuable insight with an emphasis on global market including some of the major players such as
DNATIX LTD, NEBULA GENOMICS, GENOMES.IO, ENCRYPGEN INCORPORATED, SHIVOM VENTURES LTD., GENEBLOCKCHAIN, LLC., 23ANDME, INC., 10X GENOMICS, ZENOME, IIF Management CO. LLC.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.

1 INTRODUCTION OF GLOBAL BLOCKCHAIN IN GENOMIC DATA MANAGEMENT MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL BLOCKCHAIN IN GENOMIC DATA MANAGEMENT MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL BLOCKCHAIN IN GENOMIC DATA MANAGEMENT MARKET, BY SERVICE TYPE

5.1 Overview
5.2 B2B Business Model
5.3 B2C Business Model
5.4 C2B Business Model

6 GLOBAL BLOCKCHAIN IN GENOMIC DATA MANAGEMENT MARKET, BY APPLICATION

6.1 Overview
6.2 Pharmaceutical Companies
6.3 Research Institutes
6.4 Data Owners
6.5 Others

7 GLOBAL BLOCKCHAIN IN GENOMIC DATA MANAGEMENT MARKET, BY GEOGRAPHY

7.1 Overview
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
- 7.2.3 Mexico
7.3 Europe
- 7.3.1 Germany
- 7.3.2 U.K.
- 7.3.3 France
- 7.3.4 Rest of Europe
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Rest of Asia Pacific
7.5 Rest of the World
- 7.5.1 Latin America
- 7.5.2 Middle East & Africa

8 GLOBAL BLOCKCHAIN IN GENOMIC DATA MANAGEMENT MARKET COMPETITIVE LANDSCAPE

8.1 Overview
8.2 Company Market Ranking
8.3 Key Development Strategies

9 COMPANY PROFILES

9.1 DNATIX LTD.
- 9.1.1 Overview
- 9.1.2 Financial Performance
- 9.1.3 Product Outlook
- 9.1.4 Key Developments
9.2 NEBULA GENOMICS
- 9.2.1 Overview
- 9.2.2 Financial Performance
- 9.2.3 Product Outlook
- 9.2.4 Key Developments
9.3 GENOMES.IO
- 9.3.1 Overview
- 9.3.2 Financial Performance
- 9.3.3 Product Outlook
- 9.3.4 Key Developments
9.4 ENCRYPGEN INCORPORATED
- 9.4.1 Overview
- 9.4.2 Financial Performance
- 9.4.3 Product Outlook
- 9.4.4 Key Developments
9.5 SHIVOM VENTURES LTD
- 9.5.1 Overview
- 9.5.2 Financial Performance
- 9.5.3 Product Outlook
- 9.5.4 Key Developments
9.6 GENEBLOCKCHAIN, LLC
- 9.6.1 Overview
- 9.6.2 Financial Performance
- 9.6.3 Product Outlook
- 9.6.4 Key Developments
9.7 23ANDME, INC.
- 9.7.1 Overview
- 9.7.2 Financial Performance
- 9.7.3 Product Outlook
- 9.7.4 Key Developments
9.8 10X GENOMICS
- 9.8.1 Overview
- 9.8.2 Financial Performance
- 9.8.3 Product Outlook
- 9.8.4 Key Developments
9.9 ZENOME
- 9.9.1 Overview
- 9.9.2 Financial Performance
- 9.9.3 Product Outlook
- 9.9.4 Key Developments
9.10 IIF Management Co. LLC.
- 9.10.1 Overview
- 9.10.2 Financial Performance
- 9.10.3 Product Outlook
- 9.10.4 Key Developments